Free Trial
NASDAQ:PETS

PetMed Express (PETS) Stock Price, News & Analysis

$3.29
-0.10 (-2.95%)
(As of 09/6/2024 ET)
Today's Range
$3.26
$3.42
50-Day Range
$2.94
$4.04
52-Week Range
$2.90
$11.80
Volume
191,144 shs
Average Volume
366,587 shs
Market Capitalization
$67.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50

PetMed Express MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.50 Rating Score
Upside/​Downside
6.4% Upside
$3.50 Price Target
Short Interest
Bearish
8.89% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
-0.51mentions of PetMed Express in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$1,917 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.28) to ($0.12) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.13 out of 5 stars

Retail/Wholesale Sector

191st out of 194 stocks

Drug Stores & Proprietary Stores Industry

3rd out of 4 stocks

PETS stock logo

About PetMed Express Stock (NASDAQ:PETS)

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PETS Stock Price History

PETS Stock News Headlines

Pottstown Pet Fair set for Saturday
Why billionaires are wiring money to abandoned towns
A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution.
Best pet insurance for older dogs in August 2024
Why billionaires are wiring money to abandoned towns
A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution.
Nationwide pet insurance review 2024
Q1 2024 Petmed Express Inc Earnings Call
PetMeds® Announces Fiscal 2025 First Quarter Financial Results
See More Headlines
Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/06/2024
Today
9/07/2024
Next Earnings (Estimated)
11/04/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Internet Retail
Current Symbol
NASDAQ:PETS
CUSIP
71638210
Employees
210
Year Founded
1996

Price Target and Rating

Average Stock Price Target
$3.50
High Stock Price Target
$3.50
Low Stock Price Target
$3.50
Potential Upside/Downside
+6.4%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

Net Income
$-7,460,000.00
Pretax Margin
-0.05%

Debt

Sales & Book Value

Annual Sales
$270.77 million
Cash Flow
$0.02 per share
Book Value
$4.57 per share

Miscellaneous

Free Float
20,380,000
Market Cap
$67.80 million
Optionable
Optionable
Beta
0.71

Social Links

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Ms. Christine Chambers (Age 46)
    CFO, Principal Financial Officer, Principal Accounting Officer, Treasurer & Secretary
    Comp: $305.4k
  • Mr. Mark Moseley
    Chief Technology & Information Officer
  • Mr. Daniel Job Pingree
    Chief Marketing Officer
  • Ms. Jacqueline Smith
    Vice President of People
  • Wendy Zalai
    Corporate Controller & Corporate Secretary

PETS Stock Analysis - Frequently Asked Questions

How have PETS shares performed this year?

PetMed Express' stock was trading at $7.56 at the start of the year. Since then, PETS shares have decreased by 56.5% and is now trading at $3.29.
View the best growth stocks for 2024 here
.

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) posted its quarterly earnings results on Tuesday, August, 6th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of ($0.12) by $0.30. The company had revenue of $67.95 million for the quarter, compared to analysts' expectations of $77.52 million. PetMed Express had a negative net margin of 1.24% and a negative trailing twelve-month return on equity of 3.44%.

What is Mendo Akdag's approval rating as PetMed Express' CEO?

5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are PetMed Express' major shareholders?

Top institutional shareholders of PetMed Express include Renaissance Technologies LLC (6.14%), Federated Hermes Inc. (2.94%), AQR Capital Management LLC (2.87%) and Dimensional Fund Advisors LP (1.18%). Insiders that own company stock include Mathew N Hulett, Gian Fulgoni, Jacqueline Paula Smith and Christine Chambers.
View institutional ownership trends
.

How do I buy shares of PetMed Express?

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD) and Advanced Micro Devices (AMD).

This page (NASDAQ:PETS) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners